A serene portrait of a woman sleeping comfortably in a cozy bedroom setting, highlighting relaxation.
Niels from Slaapwijsheid.nl (Pexels) / Pexels License
Lifestyle/July 29, 2026/2 min read

What Happens to Blood Sugar When You're at High Altitude? A New Study Offers Clues

Researchers tested how automated insulin pumps perform when people with Type 1 diabetes are exposed to simulated high-altitude conditions. Early findings suggest blood sugar control remains stable, but more research is needed.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

lifestyleexercisesleepstress

Key takeaways

  • A small study of 12 men with Type 1 diabetes found that blood sugar levels stayed within healthy ranges during 48 hours of simulated altitude exposure up to 3,500 meters
  • The MiniMed 780G hybrid closed-loop insulin system adjusted insulin delivery appropriately without major changes needed
  • This was an exploratory study with limited participants, so larger studies are needed before drawing firm conclusions about altitude and insulin delivery
  • People planning high-altitude activities should discuss their specific situation with their diabetes care team, as individual responses may vary

Why Altitude Matters for People With Type 1 Diabetes

For people with Type 1 diabetes, physical activity—including mountain climbing, hiking, or travel to high altitudes—requires careful planning. When you're at high altitude, your body experiences lower oxygen levels, which can affect how insulin works and how your body uses glucose. Until now, there has been limited research on how modern insulin pumps handle these conditions.

How the Study Worked

Researchers invited 12 men with Type 1 diabetes (average age 40, with diabetes for about 22 years) to spend 48 hours in a special chamber that simulated altitude up to 3,500 meters (about 11,500 feet) while keeping normal air pressure. All participants used the MiniMed 780G, a hybrid closed-loop insulin pump that automatically adjusts insulin delivery based on glucose readings.

The study team measured blood sugar control, insulin use, carbohydrate intake, and a wide range of body chemistry markers before, during, and after the altitude exposure. They also compared results with 13 healthy men without diabetes who underwent the same altitude simulation.

What the Results Showed

Blood sugar levels remained stable and within recommended targets throughout the 48-hour period. The automated insulin pump made adjustments as needed, and total insulin delivery stayed consistent. Daily carbohydrate intake and the pattern of insulin boluses (doses given at mealtime) did not change significantly.

The only notable difference was a slight increase in blood sugar variability after the hypoxia period ended compared to during the exposure itself, though this remained within safe ranges. Some immune and growth markers differed between the Type 1 diabetes group and healthy controls, but these differences did not affect blood sugar control.

What This Means and What's Still Unknown

This early-stage research suggests that modern hybrid closed-loop insulin systems may handle short-term altitude exposure without major disruptions to blood sugar control. However, this was a small study of only 12 men in a controlled laboratory setting, so the results may not apply to everyone or to real-world mountain activities.

If you're planning a high-altitude adventure, talk with your diabetes care team well in advance. They can help you prepare, monitor your blood sugar more frequently, and adjust your insulin plan if needed. Individual responses to altitude vary, and many factors—like physical activity level, acclimatization time, and personal health—affect how your diabetes responds.

Evidence label

Source: Journal of diabetes science and technology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.